An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer (NURE-Combo)

NCT04876313 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Muscle-Invasive Bladder Carcinoma

Interventions

DRUG: Nivolumab + Nab-paclitaxel
DRUG: Nivolumab

Sponsor

IRCCS San Raffaele

Collaborators

[object Object]